Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Open-label, Prospective, Randomized Study to Show Long-term Efficacy of DCB Treatment With Bail-out BRS in Comparison to BRS Treatment of De-novo Native Coronary Artery Lesions in a Relatively Young PCI Population.

NCT07038408 is registered in ClinicalTrials.gov with Ceric Sàrl as lead sponsor.

NCT NCT07038408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07038408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Open-label, Prospective, Randomized Study to Show Long-term Efficacy of DCB Treatment With Bail-out BRS in Comparison to BRS Treatment of De-novo Native Coronary Artery Lesions in a Relatively Young PCI Population.
Lead sponsor
Ceric Sàrl
Phase
Not applicable
Overall status
Recruiting
Start date
April 24, 2026
Completion date
March 31, 2032
Enrollment
2,256 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs), bioresorbable scaffold, drug coated balloon, percutaneous coronary intervention (pci)